Advancing Hyperlipidemia Management: Nonstatin Therapies in Guideline-Based Care
This Formulary Watch® Executive Brief is sponsored by Esperion.
This Executive Brief discusses the use of nonstatin therapies in patients with primary hyperlipidemia at high cardiovascular risk.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
